Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06090110

Vagal Nerve Stimulation in Irritable Bowel Syndrome

Clinical Efficacy of Transcutaneous Auricular Vagal Nerve Stimulation in Irritable Bowel Syndrome and the Potential Predictive Role for the Vagal-Autonomic Neurosignature

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
166 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This randomized control trial aims to evaluate the effect of transcutaneous auricular vagal nerve stimulation in patients with irritable bowel syndrome. The intervention will be 8 weeks of treatment with a vagal nerve stimulator. The main objectives are: * To evaluate the clinical response, defined as a decrease of at least 50 points on the IBS-SSS questionnaire, of the treatment. * To ascertain whether the autonomic-vagal neurosignature, derived from pre-treatment registration of symptom profiles, autonomic responses and imaging of neuronal activity as a reaction to stress is able to predict therapeutic response to tVNS accurately. * To evaluate the effect of treatment on quality of life * To evaluate the effect of treatment on depression * To evaluate the effect of treatment on anxiety Participants will be asked to wear a wearable (Fitbit) and fill out a daily questionnaire for one week. Thereafter, a functional brain MRI will be performed. In the intervention group patients will receive transcutaneous nerve stimulation for 8-weeks at home. The comparison group will receive the same device but with a non-conducting electrode. Patients fill out weekly questionnaires during the treatment period and at follow-up moments 3 and 6 months after finishing the treatment period.

Conditions

Interventions

TypeNameDescription
DEVICEVagal Nerve StimulationTranscutaneous Auricular Vagal Nerve Stimulation
DEVICESham stimulationSham stimulation with a non-conduction electrode

Timeline

Start date
2023-12-01
Primary completion
2025-11-01
Completion
2026-11-01
First posted
2023-10-19
Last updated
2024-08-02

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06090110. Inclusion in this directory is not an endorsement.